VedaBio Patents

Patent portfolio assigned to VedaBio (verified via public assignee records). Estimated patent count: 26. CRISPR molecular-detection platform (formerly LabSimply, renamed Aug 2023). Partners: Mammoth Biosciences (non-exclusive CRISPR IP license), Siemens Healthineers (strategic agreement + Series A extension). Has granted patent US11884921B2 'Signal boost cascade assay'; ~26 patents filed per 360Dx (estimate from press). No competitors named in sources.